Inflammasome activation and innate immunity in Alzheimer's disease

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Brain Pathology

• Publication date

  2017-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/bpa.12483PMID 28019679PMCID PMC8029274
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activation of phagocytic activity in astrocytes by reduced expression of the inflammasome component ASC and its implication in a mouse model of Alzheimer disease

  2016influential reference
• Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer's disease in rodent models

  2016cited by this paper
• Innate immunity in Alzheimer's disease

  2015cited by this paper
• NLRP3 inflammasome activation by mitochondrial reactive oxygen species plays a key role in long-term cognitive impairment induced by paraquat exposure.

  2015cited by this paper
• Neuronal NLRP1 inflammasome activation of Caspase-1 coordinately regulates inflammatory interleukin-1-beta production and axonal degeneration-associated Caspase-6 activation

  2015cited by this paper
• ASC has extracellular and prionoid activities that propagate inflammation

  2014cited by this paper
• Amyloid-β induces NLRP1-dependent neuronal pyroptosis in models of Alzheimer's disease

  2014cited by this paper
• Antimalarial Drug Artemisinin Extenuates Amyloidogenesis and Neuroinflammation in APPswe/PS1dE9 Transgenic Mice via Inhibition of Nuclear Factor‐κB and NLRP3 Inflammasome Activation

  2013cited by this paper
• Differential pathways for interleukin-1β production activated by chromogranin A and amyloid β in microglia.

  2013cited by this paper
• Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.

  2013cited by this paper
• CD36 coordinates NLRP3 inflammasome activation by facilitating the intracellular nucleation from soluble to particulate ligands in sterile inflammation

  2013cited by this paper
• Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study

  2012cited by this paper
• NLRP3 is activated in Alzheimer´s disease and contributes to pathology in APP/PS1 mice

  2012cited by this paper
• The NALP3 inflammasome is involved in the innate immune response to amyloid-β

  2008cited by this paper
• Role of Escherichia coli Curli Operons in Directing Amyloid Fiber Formation

  2002cited by this paper

• Deletion of NLRP3 gene blocks traumatic brain injury induced abnormal immune response in 3xTg AD mice

  2026cites this paper
• Exploring the Gut-Brain Connection: Are Probiotics the Next Frontier in Alzheimer's Disease Treatment?

  2026cites this paper
• Glia inflammation and cell death pathways drive disease progression in preclinical and early AD

  2025influential citation
• Glycolytic reprogramming during microglial polarization in neurological diseases

  2025cites this paper
• Effects of exercise on neuroinflammation in age-related neurodegenerative disorders

  2025cites this paper
• STING-mediated neuroinflammation: a therapeutic target in neurodegenerative diseases

  2025cites this paper
• Ergolide Regulates Microglial Activation and Inflammatory-Mediated Dysfunction: A Role for the Cysteinyl Leukotriene Pathway

  2025cites this paper
• Divergent disruptive effects of soluble recombinant tau assemblies on synaptic plasticity in vivo

  2025cites this paper
• Kai-Xin-San ameliorates mild cognitive impairment in SAMP8 mice by inhibiting neuroinflammation and pyroptosis via NLRP3/Caspase-1 pathway modulation

  2025cites this paper
• The neuroimmune nexus: unraveling the role of the mtDNA-cGAS-STING signal pathway in Alzheimer’s disease

  2025cites this paper
• Microglial Modulation in Alzheimer's Disease: Central Players in Neuroinflammation and Pathogenesis.

  2025cites this paper
• Microglial NLRP3 Inflammasomes in Alzheimer’s Disease Pathogenesis: From Interaction with Autophagy/Mitophagy to Therapeutics

  2025cites this paper
• Xanthoceras sorbifolium oil ameliorates neuroinflammation and learning and memory impairment in Alzheimer's disease mice by regulating gut microbiota and unsaturated fatty acid metabolism

  2025cites this paper
• Comparison of Methods of Detecting IL-1β in the Blood of Alzheimer’s Disease Subjects

  2025cites this paper
• Neural Stem Cell-conditioned Medium Protected Against Cognitive Dysfunction in APP/PS1 Mice

  2025cites this paper
• Large- and Small-Animal Studies of Safety, Pharmacokinetics (PK), and Biodistribution of Inflammasome-Targeting Nanoligomer in the Brain and Other Target Organs

  2024cites this paper
• Suppression of MT5-MMP Reveals Early Modulation of Alzheimer’s Pathogenic Events in Primary Neuronal Cultures of 5xFAD Mice

  2024cites this paper
• Therapeutic approaches to microglial dysfunction in Alzheimer's disease: Enhancing phagocytosis and metabolic regulation.

  2024cites this paper
• Functional Characterization of an Arylsulfonamide-Based Small-Molecule Inhibitor of the NLRP3 Inflammasome

  2024cites this paper
• The intricate interplay between microglia and adult neurogenesis in Alzheimer’s disease

  2024cites this paper
• The Neuro-Inflammatory Microenvironment: An Important Regulator of Stem Cell Survival in Alzheimer’s Disease

  2024cites this paper
• Molecular Mechanisms Linking Osteoarthritis and Alzheimer’s Disease: Shared Pathways, Mechanisms and Breakthrough Prospects

  2024cites this paper
• DNA hypomethylation promotes the expression of CASPASE-4 which exacerbates inflammation and amyloid-β deposition in Alzheimer’s disease

  2024cites this paper
• Neuroinflammation Biomarkers in the AT(N) Framework Across the Alzheimer’s Disease Continuum

  2023cites this paper
• The implication of infection with respiratory syncytial virus in pediatric recurrent wheezing and asthma: knowledge expanded post-COVID-19 era

  2023cites this paper
• Longitudinal cerebrospinal fluid measurements show glial hypo- and hyperactivation in predementia Alzheimer’s disease

  2023cites this paper
• Modulating the polarization phenotype of microglia - a valuable strategy for central nervous system diseases.

  2023cites this paper
• Effects of amyloid β (Aβ)42 and Gasdermin D on the progression of Alzheimer’s disease in vitro and in vivo through the regulation of astrocyte pyroptosis

  2023cites this paper
• Microglial response to aging and neuroinflammation in the development of neurodegenerative diseases

  2023cites this paper
• Neuroinflammation: A Common Pathway in Alzheimer’s Disease and Epilepsy

  2023cites this paper
• The dual face of microglia (M1/M2) as a potential target in the protective effect of nutraceuticals against neurodegenerative diseases

  2023cites this paper
• DNA hypomethylation promotes the expression of CASPASE-4 which exacerbates neuroinflammation and amyloid-β deposition in Alzheimer’s disease The Ohio State University College of Medicine

  2023influential citation
• Methods to Study Inflammasome Activation in the Central Nervous System: Immunoblotting and Immunohistochemistry.

  2023cites this paper
• Inhibition of Pro-Inflammatory Microglia with Minocycline Improves Cognitive and Sleep-Wake Dysfunction Under Respiratory Stress in a Sporadic Model for Alzheimer’s Disease

  2023cites this paper
• Cathepsin B abundance, activity and microglial localisation in Alzheimer’s disease-Down syndrome and early onset Alzheimer’s disease; the role of elevated cystatin B

  2023cites this paper
• Is Drp1 a link between mitochondrial dysfunction and inflammation in Alzheimer’s disease?

  2023cites this paper
• Role of microglia autophagy and mitophagy in age-related neurodegenerative diseases

  2023cites this paper
• The Potential Effect of Dapsone on the Inflammatory Reactions in Covid-19: Staggering view.

  2023cites this paper
• Effects of Current Psychotropic Drugs on Inflammation and Immune System.

  2023cites this paper
• Immunity orchestrates a bridge in gut-brain axis of neurodegenerative diseases.

  2023cites this paper
• A novel strategy for bioactive natural products targeting NLRP3 inflammasome in Alzheimer’s disease

  2023cites this paper
• Establishing a competing endogenous RNA (ceRNA)-immunoregulatory network associated with the progression of Alzheimer’s disease

  2022cites this paper
• Microglia Polarization From M1 to M2 in Neurodegenerative Diseases

  2022influential citation
• A Therapeutic Nanovaccine that Generates Anti‐Amyloid Antibodies and Amyloid‐specific Regulatory T Cells for Alzheimer's Disease

  2022cites this paper
• Common NLRP3 inflammasome inhibitors and Covid-19: Divide and conquer

  2022cites this paper
• Stable cerebrospinal fluid neurogranin and β-site amyloid precursor protein cleaving enzyme 1 levels differentiate predementia Alzheimer’s disease patients

  2022cites this paper
• Relationship of NLRP3 inflammasome with periodontal, endodontic and related systemic diseases

  2022cites this paper
• Innate immune activation: Parallels in alcohol use disorder and Alzheimer’s disease

  2022cites this paper
• Identifying an Optimal Neuroinflammation Treatment Using a Nanoligomer Discovery Engine.

  2022cites this paper
• REPS1 as a Potential Biomarker in Alzheimer’s Disease and Vascular Dementia

  2022cites this paper
• Non-Communicable Neurological Disorders and Neuroinflammation

  2022cites this paper
• Targeting protein phosphatases for the treatment of inflammation-related diseases: From signaling to therapy

  2022influential citation
• Focus on the Role of the NLRP3 Inflammasome in Multiple Sclerosis: Pathogenesis, Diagnosis, and Therapeutics

  2022cites this paper
• Gut–Brain Axis: Role of Gut Microbiota in Neurodegenerative Disease

  2022cites this paper
• A2A Adenosine Receptor: A Possible Therapeutic Target for Alzheimer’s Disease by Regulating NLRP3 Inflammasome Activity?

  2022cites this paper
• Hippocampal but Not Serum Cytokine Levels Are Altered by Traffic-Related Air Pollution in TgF344-AD and Wildtype Fischer 344 Rats in a Sex- and Age-Dependent Manner

  2022cites this paper
• Jiedu-Yizhi Formula Improves Cognitive Impairment in an Aβ25–35-Induced Rat Model of Alzheimer's Disease by Inhibiting Pyroptosis

  2022cites this paper
• The Role of Neuroinflammation in Cognitive Functions and Social Interaction in Mice with Age-Dependent Neurodegeneration

  2022cites this paper
• Plasmalogens ensure the stability of non-neuronal (microglial) cells during long-term cytotoxicity

  2021cites this paper
• Decreased pH in the aging brain and Alzheimer's disease.

  2021cites this paper
• A Novel Treatment Strategy by Natural Products in NLRP3 Inflammasome-Mediated Neuroinflammation in Alzheimer’s and Parkinson’s Disease

  2021cites this paper
• Metforminium Decavanadate (MetfDeca) Treatment Ameliorates Hippocampal Neurodegeneration and Recognition Memory in a Metabolic Syndrome Model

  2021cites this paper
• The Role of the Inflammasome in Neurodegenerative Diseases

  2021cites this paper
• Amyloid-β: A double agent in Alzheimer's disease?

  2021cites this paper
• Cytokine signaling convergence regulates the microglial state transition in Alzheimer’s disease

  2021cites this paper
• Role of Neuroinflammation in Neurodegenerative Disorders

  2021cites this paper
• Identification of key transcriptome biomarkers based on a vital gene module associated with pathological changes in Alzheimer’s disease

  2021cites this paper
• Systemic Actions of SGLT2 Inhibition on Chronic mTOR Activation as a Shared Pathogenic Mechanism between Alzheimer’s Disease and Diabetes

  2021cites this paper
• Neuroinflammation: The next target of exosomal microRNAs derived from mesenchymal stem cells in the context of neurological disorders

  2021cites this paper
• Roles of Inflammasome in Cigarette Smoke-Related Diseases and Physiopathological Disorders: Mechanisms and Therapeutic Opportunities

  2021cites this paper
• Anti-inflammatory Activity of a Polypeptide Fraction From Achyranthes bidentate in Amyloid β Oligomers Induced Model of Alzheimer’s Disease

  2021cites this paper
• (-)-Epicatechin ameliorates cigarette smoke-induced lung inflammation via inhibiting ROS/NLRP3 inflammasome pathway in rats with COPD.

  2021cites this paper
• Novel insights into RIPK1 as a promising target for future Alzheimer's disease treatment.

  2021cites this paper
• Involvement of IL-10R/STAT3 pathway in amyloid β clearance by microlgia in Alzheimer's disease.

  2021cites this paper
• Demyelination of the Optic Nerve: An Underlying Factor in Glaucoma?

  2021cites this paper
• Downregulating expression of OPTN elevates neuroinflammation via AIM2 inflammasome- and RIPK1-activating mechanisms in APP/PS1 transgenic mice

  2021cites this paper
• Anti-Neuroinflammatory Effects of a Semi-Synthetic Isoorientin-Based Glycogen Synthase Kinase-3β Inhibitor in Lipopolysaccharide-Activated Microglial Cells.

  2021cites this paper
• WITHDRAWN: Common NLRP3 inflammasome inhibitors and Covid-19: Divide and Conquer

  2021cites this paper
• Novel preventive mechanisms of vitamin B6 against inflammation, inflammasome, and chronic diseases

  2020cites this paper
• Transcriptome Analyses in BV2 Microglial Cells Following Treatment With Amino-Terminal Fragments of Apolipoprotein E

  2020cites this paper
• Tetrahydrobioterin (BH4) pathway: from metabolism to neuropsychiatry.

  2020cites this paper
• Neurovascular Inflammaging in Health and Disease

  2020cites this paper
• Genetic risk of dementia modifies obesity effects on white matter myelin in cognitively healthy adults.

  2020cites this paper
• Epilepsy and Alzheimer's Disease: potential mechanisms for an association.

  2020cites this paper
• Danger-Sensing/Patten Recognition Receptors and Neuroinflammation in Alzheimer’s Disease

  2020cites this paper
• An Immunomodulatory Therapeutic Vaccine Targeting Oligomeric Amyloid-β

  2020cites this paper
• Improving Effects of Hop-Derived Bitter Acids in Beer on Cognitive Functions: A New Strategy for Vagus Nerve Stimulation

  2020cites this paper
• Mechanisms of NLRP3 Inflammasome Activation: Its Role in the Treatment of Alzheimer’s Disease

  2020cites this paper
• Locus Coeruleus and neurovascular unit: From its role in physiology to its potential role in Alzheimer’s disease pathogenesis

  2020cites this paper
• Therapeutic Role of Inflammasome Inhibitors in Neurodegenerative Disorders.

  2020cites this paper
• Blueberry Extracts as a Novel Approach to Prevent Ozone-Induced Cutaneous Inflammasome Activation

  2020cites this paper
• Tetrahydrobioterin (BH4) Pathway: From Metabolism to Neuropsychiatry

  2020cites this paper
• The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer's disease

  2020cites this paper
• Amyloid beta acts synergistically as a pro-inflammatory cytokine

  2020cites this paper
• Physical Exercise Inhibits Inflammation and Microglial Activation

  2019cites this paper
• Choline Supplementation Ameliorates Behavioural Deficits and Alzheimer's Disease-Like Pathology in Transgenic APP/PS1 Mice.

  2019cites this paper
• Megalencephalic Leukoencephalopathy with Subcortical Cysts Protein-1 (MLC1) Counteracts Astrocyte Activation in Response to Inflammatory Signals

  2019cites this paper
• Interleukin-4 affects microglial autophagic flux

  2019cites this paper
• Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer’s disease

  2019cites this paper
• Diet in Parkinson's Disease: Critical Role for the Microbiome

  2019cites this paper